In support of these previous results, we found that Peroxiredoxin-1 mRNA was significantly upregulated in human pancreatic tumors and that its high expression correlated with shortened patient survival (Figure 1A,B). The gene discussed is PRDX1; the disease is pancreatic neoplasm.